Xenon (XENE) Trading Summary
Xenon (XENE) ended the 24‑hour trading period at 08:28 AM Central Europe on Thursday 22 October 2026 with a decline of 0.88 %.
- Current price: USD 35.95
- Shares outstanding: 96.8 million
- Market capitalization: USD 3.5 billion
- Volume traded in last 24 h: USD 38.8 million
Since the close of the previous month, Xenon has fallen 8.03 %.
- 200‑day simple moving average: USD 52.54
- 52‑week high: USD 72.66 (09 July 2026)
- 52‑week low: USD 33.38 (16 October 2026)
Related Canadian Stocks – 24‑Hour Performance
| Symbol | Current price (CAD) | % change | Market cap (CAD) | P/E ratio |
|---|---|---|---|---|
| DOO.TO (Brp /Ca) | 78.53 | –0.28 % | 5.6 bn | 49.91 |
| GEI.TO (Gibson Energy) | 33.59 | +1.02 % | 5.8 bn | 33.55 |
| AYA.TO (Aya Gold & Silver) | 37.32 | +1.11 % | 5.3 bn | 34.36 |
| AQN.TO (Algonquin Power & Utilities) | 7.44 | +1.22 % | 5.7 bn | 21.94 |
| NPI.TO (Northland Power) | 22.22 | +1.41 % | 5.9 bn | – |
Company Overview
Xenon Pharmaceuticals Inc. is a clinical‑stage biopharmaceutical company headquartered in Burnaby, Canada. The company focuses on developing therapeutics for diseases caused by ion‑channel mutations and offers Glybera, a gene‑therapy product targeting adult patients with the orphan lipid disorder lipoprotein lipase deficiency. Xenon is listed on the Nasdaq exchange and completed its initial public offering on 5 November 2014. The company’s website is www.xenon‑pharma.com .
